申请人:HOFFMANN LA ROCHE
公开号:WO2005003117A1
公开(公告)日:2005-01-13
The present invention relates to imidazole derivatives of the general formula (I), wherein R1, R2, R3 and R4 are as defined in the description as well as pharmaceutically acceptable salts and processes for the preparation thereof. The invention also relates to medicaments containing said imidazole derivatives and to their use for the manufacture of medicaments for the treatment and prevention of mGluR5 receptor mediated disorders such as acute and/or chronic neurological disorders, in particular anxiety, or for the treatment of chronic and acute pain.
本发明涉及一般式(I)的咪唑衍生物,其中R1、R2、R3和R4如描述中所定义,以及药学上可接受的盐和制备方法。该发明还涉及含有所述咪唑衍生物的药物以及它们用于制备治疗和预防mGluR5受体介导的疾病的药物,如急性和/或慢性神经系统疾病,尤其是焦虑症,或用于治疗慢性和急性疼痛。